{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:28:55Z","timestamp":1772166535094,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["2235783"],"award-info":[{"award-number":["2235783"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2023-67013-39901"],"award-info":[{"award-number":["2023-67013-39901"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michigan State University Chemical Engineering and Materials Science Department Startup Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"DOI":"10.1186\/s13321-025-01020-5","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:24:22Z","timestamp":1746447862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting inhibitors of OATP1B1 via heterogeneous OATP-ligand interaction graph neural network (HOLIgraph)"],"prefix":"10.1186","volume":"17","author":[{"given":"Mehrsa","family":"Mardikoraem","sequence":"first","affiliation":[]},{"given":"Joelle N.","family":"Eaves","sequence":"additional","affiliation":[]},{"given":"Theodore","family":"Belecciu","sequence":"additional","affiliation":[]},{"given":"Nathaniel","family":"Pascual","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Aljets","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Hagenbuch","sequence":"additional","affiliation":[]},{"given":"Erik M.","family":"Shapiro","sequence":"additional","affiliation":[]},{"given":"Benjamin J.","family":"Orlando","sequence":"additional","affiliation":[]},{"given":"Daniel R.","family":"Woldring","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2024.100023","volume":"77","author":"B Hagenbuch","year":"2024","unstructured":"Hagenbuch B, Stieger B, Locher KP (2024) Organic anion transporting polypeptides (OATPs\/SLCOs): pharmacology, toxicology, structure, and transport mechanisms. Pharmacol Rev 77:100023","journal-title":"Pharmacol Rev"},{"key":"1020_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/cpt.1174","volume":"104","author":"A Schlessinger","year":"2018","unstructured":"Schlessinger A et al (2018) Molecular modeling of drug-transporter interactions-an international transporter consortium perspective. Clin Pharmacol Ther 104:818\u2013835","journal-title":"Clin Pharmacol Ther"},{"key":"1020_CR3","unstructured":"US Food and Drug Administration. In vitro drug interaction studies-cytochrome p450 enzyme-and transporter-mediated drug interactions guidance for industry. 2020. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm. Accessed 2 Oct 2024"},{"key":"1020_CR4","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.2174\/0929867311320160005","volume":"20","author":"Y Xu","year":"2013","unstructured":"Xu Y et al (2013) Computational models for predicting interactions with membrane transporters. Curr Med Chem 20:2118\u20132136","journal-title":"Curr Med Chem"},{"key":"1020_CR5","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1021\/jm300212s","volume":"55","author":"M Karlgren","year":"2012","unstructured":"Karlgren M et al (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): Influence of protein expression on drug-drug interactions. J Med Chem 55:4740\u20134763","journal-title":"J Med Chem"},{"key":"1020_CR6","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1021\/acs.molpharmaceut.2c00662","volume":"19","author":"TR Lane","year":"2022","unstructured":"Lane TR et al (2022) Machine learning models identify new inhibitors for human OATP1B1. Mol Pharm 19:4320\u20134332","journal-title":"Mol Pharm"},{"key":"1020_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202300270","author":"H Duan","year":"2024","unstructured":"Duan H et al (2024) In silico prediction of inhibitors for multiple transporters via machine learning methods. Mol Inform. https:\/\/doi.org\/10.1002\/minf.202300270","journal-title":"Mol Inform"},{"key":"1020_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.dmpk.2015.06.004","volume":"30","author":"H You","year":"2015","unstructured":"You H et al (2015) Computational classification models for predicting the interaction of compounds with hepatic organic ion importers. Drug Metabol Pharmacokinet 30:347\u2013351","journal-title":"Drug Metabol Pharmacokinet"},{"key":"1020_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41422-023-00870-8","volume":"33","author":"Z Shan","year":"2023","unstructured":"Shan Z et al (2023) Cryo-EM structures of human organic anion transporting polypeptide OATP1B1. Cell Res 33:940\u2013951","journal-title":"Cell Res"},{"key":"1020_CR10","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.3390\/ijms24098180","volume":"24","author":"N Aniceto","year":"2023","unstructured":"Aniceto N, Albuquerque TS, Bonif\u00e1cio VD, Guedes RC, Martinho N (2023) Using machine learning and molecular docking to leverage urease inhibition data for virtual screening. Int J Mol Sci 24:8180","journal-title":"Int J Mol Sci"},{"key":"1020_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89386.2","volume":"12","author":"M Karelina","year":"2023","unstructured":"Karelina M, Noh JJ, Dror RO (2023) How accurately can one predict drug binding modes using alphafold models? eLife 12:RP89386","journal-title":"eLife"},{"key":"1020_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105920","volume":"26","author":"V Scardino","year":"2023","unstructured":"Scardino V, Filippo JID, Cavasotto CN (2023) How good are alphafold models for docking-based virtual screening? iScience 26:105920","journal-title":"iScience"},{"key":"1020_CR13","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme MF et al (2021) Plip 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 49:W530\u2013W534","journal-title":"Nucleic Acids Res"},{"key":"1020_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inform Model 50:742\u2013754","journal-title":"J Chem Inform Model"},{"key":"1020_CR15","unstructured":"Rdkit: Open-source cheminformatics. http:\/\/rdkit.org\/. Accessed 5 Mar 2024"},{"key":"1020_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1021\/acs.jcim.6b00508","volume":"57","author":"N Shaikh","year":"2017","unstructured":"Shaikh N, Sharma M, Garg P (2017) Selective fusion of heterogeneous classifiers for predicting substrates of membrane transporters. J Chem Inform Model 57:594\u2013607","journal-title":"J Chem Inform Model"},{"key":"1020_CR17","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/mol.112.084152","volume":"83","author":"TD Bruyn","year":"2013","unstructured":"Bruyn TD et al (2013) Structure-based identification of oatp1b1\/3 inhibitorss. Mol Pharmacol 83:1257\u20131267","journal-title":"Mol Pharmacol"},{"key":"1020_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102378","author":"NJ Wright","year":"2022","unstructured":"Wright NJ, Lee SY (2022) Recent advances on the inhibition of human solute carriers: therapeutic implications and mechanistic insights. Curr Opin Struct Biol. https:\/\/doi.org\/10.1016\/j.sbi.2022.102378","journal-title":"Curr Opin Struct Biol"},{"key":"1020_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/prot.21086","volume":"65","author":"J Meiler","year":"2006","unstructured":"Meiler J, Baker D (2006) ROSETTALIGAND: Protein-small molecule docking with full side-chain flexibility. Proteins Struct Funct Genet 65:538\u2013548","journal-title":"Proteins Struct Funct Genet"},{"key":"1020_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050769","volume":"7","author":"KW Kaufmann","year":"2012","unstructured":"Kaufmann KW, Meiler J (2012) Using RosettaLigand for small molecule docking into comparative models. PLoS ONE 7:e50769","journal-title":"PLoS ONE"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-025-01020-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-025-01020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T12:24:23Z","timestamp":1746447863000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-025-01020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1186\/s13321-025-01020-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.01.615464","asserted-by":"object"}]},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}